Yellow fever: Status of research, development, and access to countermeasures against an emerging epidemic
GHTC breaks down the status of R&D for vaccines, drugs, and diagnostics against yellow fever.
Sign up to receive news and updates from GHTC.
GHTC breaks down the status of R&D for vaccines, drugs, and diagnostics against yellow fever.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
As happens every May, the World Health Organization’s (WHO) highest governing body, the World Health Assembly (WHA), met last week for its 69th annual meeting in Geneva, Switzerland. The agenda was the most packed in recent memory, consisting of more than 70 discussion items, many of which were controversial. Despite the lengthy agenda and difficult conversations, the WHA made two key decisions impacting global health research and development (R&D).
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.